Skip to main content

Kiniksa Pharmaceuticals International, plc 10-K for FY2023

Kiniksa Pharmaceuticals International, plc (KNSA)

10-K 2024-02-28 For: 2023-12-31
View Original
Added on April 04, 2026

About this 10-K

Kiniksa Pharmaceuticals International, plc filed this 10-K on February 28, 2024, covering the fiscal year ended December 31, 2023 (FY2023).

Headline figures

Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$270.26M
up 22.7% from $220.18M a year earlier
Net income
$14.08M
down 92.3% from net income of $183.36M a year earlier
Diluted EPS
$0.20
down 92.3% from $2.60 a year earlier